Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
HPTN 069/ACTG 5305 was designed to evaluate potential new PrEP regimens that included maraviroc, tenofovir disoproxil fumarate, and/or emtricitabine. The current analyses assessed antiretroviral (ARV) plasma concentrations in relation to sexual behavior in 224 cisgender men who have sex with men and 2 transgender women at risk for HIV. Poisson generalized estimating equations (GEE) regression were used to test for associations between self-reported sexual behavior, sociodemographic, behavioral variables, and study drug levels The median (IQR) age was 30 [25, 37] years old; 48.2% had completed college; 27.4% were Black and 21.7% Latino. At weeks 24 and 48, one third of participants reported condomless anal sex (CAS) in the prior month with more than one partner. CAS was associated with daily ARV drug use (χ2 = 12.64, p = 0.002). Older individuals and those with greater education were more likely to ingest ARV drugs daily (χ2 = 9.36, p = 0.009 and χ2 = 8.63, p = 0.013, respectively), while neither race nor ethnicity was associated with daily ARV drug use. Participants who reported recent condomless anal sex and/or advanced education had higher rates of daily ARV drug use. These data support the need for ongoing adherence counseling in clinical trials of new PrEP modalities.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
AIDS and behavior - 26(2022), 12 vom: 10. Dez., Seite 4107-4114 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mayer, Kenneth H [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
99YXE507IL |
|---|
| Anmerkungen: |
Date Completed 09.11.2022 Date Revised 28.10.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10461-022-03736-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342088785 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342088785 | ||
| 003 | DE-627 | ||
| 005 | 20231226013256.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10461-022-03736-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1140.xml |
| 035 | |a (DE-627)NLM342088785 | ||
| 035 | |a (NLM)35687192 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mayer, Kenneth H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305) |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.11.2022 | ||
| 500 | |a Date Revised 28.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
| 520 | |a HPTN 069/ACTG 5305 was designed to evaluate potential new PrEP regimens that included maraviroc, tenofovir disoproxil fumarate, and/or emtricitabine. The current analyses assessed antiretroviral (ARV) plasma concentrations in relation to sexual behavior in 224 cisgender men who have sex with men and 2 transgender women at risk for HIV. Poisson generalized estimating equations (GEE) regression were used to test for associations between self-reported sexual behavior, sociodemographic, behavioral variables, and study drug levels The median (IQR) age was 30 [25, 37] years old; 48.2% had completed college; 27.4% were Black and 21.7% Latino. At weeks 24 and 48, one third of participants reported condomless anal sex (CAS) in the prior month with more than one partner. CAS was associated with daily ARV drug use (χ2 = 12.64, p = 0.002). Older individuals and those with greater education were more likely to ingest ARV drugs daily (χ2 = 9.36, p = 0.009 and χ2 = 8.63, p = 0.013, respectively), while neither race nor ethnicity was associated with daily ARV drug use. Participants who reported recent condomless anal sex and/or advanced education had higher rates of daily ARV drug use. These data support the need for ongoing adherence counseling in clinical trials of new PrEP modalities | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a HIV prevention | |
| 650 | 4 | |a MSM | |
| 650 | 4 | |a Maraviroc | |
| 650 | 4 | |a PrEP | |
| 650 | 4 | |a Tenofovir | |
| 650 | 7 | |a Emtricitabine |2 NLM | |
| 650 | 7 | |a G70B4ETF4S |2 NLM | |
| 650 | 7 | |a Tenofovir |2 NLM | |
| 650 | 7 | |a 99YXE507IL |2 NLM | |
| 650 | 7 | |a Maraviroc |2 NLM | |
| 650 | 7 | |a MD6P741W8A |2 NLM | |
| 650 | 7 | |a Anti-HIV Agents |2 NLM | |
| 650 | 7 | |a Anti-Retroviral Agents |2 NLM | |
| 700 | 1 | |a Yuhas, Krista |e verfasserin |4 aut | |
| 700 | 1 | |a Amico, K Rivet |e verfasserin |4 aut | |
| 700 | 1 | |a Wilkin, Timothy |e verfasserin |4 aut | |
| 700 | 1 | |a Landovitz, Raphael J |e verfasserin |4 aut | |
| 700 | 1 | |a Richardson, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Marzinke, Mark A |e verfasserin |4 aut | |
| 700 | 1 | |a Hendrix, Craig W |e verfasserin |4 aut | |
| 700 | 1 | |a Eshleman, Susan H |e verfasserin |4 aut | |
| 700 | 1 | |a Cottle, Leslie M |e verfasserin |4 aut | |
| 700 | 1 | |a Marcus, Cheryl |e verfasserin |4 aut | |
| 700 | 1 | |a Chege, Wairimu |e verfasserin |4 aut | |
| 700 | 1 | |a Rinehart, Alex R |e verfasserin |4 aut | |
| 700 | 1 | |a Rooney, James F |e verfasserin |4 aut | |
| 700 | 1 | |a Andrew, Philip |e verfasserin |4 aut | |
| 700 | 1 | |a Salata, Robert A |e verfasserin |4 aut | |
| 700 | 1 | |a Magnus, Manya |e verfasserin |4 aut | |
| 700 | 1 | |a Farley, Jason E |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Albert Y |e verfasserin |4 aut | |
| 700 | 1 | |a Frank, Ian |e verfasserin |4 aut | |
| 700 | 1 | |a Ho, Ken |e verfasserin |4 aut | |
| 700 | 1 | |a Santana, Jorge |e verfasserin |4 aut | |
| 700 | 1 | |a Stekler, Joanne D |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Ying Q |e verfasserin |4 aut | |
| 700 | 1 | |a McCauley, Marybeth |e verfasserin |4 aut | |
| 700 | 1 | |a Gulick, Roy M |e verfasserin |4 aut | |
| 700 | 0 | |a HPTN 069/ACTG 5305 Study Team |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t AIDS and behavior |d 1997 |g 26(2022), 12 vom: 10. Dez., Seite 4107-4114 |w (DE-627)NLM09651440X |x 1573-3254 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2022 |g number:12 |g day:10 |g month:12 |g pages:4107-4114 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10461-022-03736-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2022 |e 12 |b 10 |c 12 |h 4107-4114 | ||